Magnetar Financial LLC Rx Sight, Inc. Transaction History

Magnetar Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$12.58 - $16.68 $1.03 Million - $1.37 Million	-81,905 Reduced 48.14%	88,236 $1.47 Million
Q4 2022 Feb 14, 2023	BUY	$9.93 - $14.2 $504,642 - $721,644	50,820 Added 42.59%	170,141 $2.16 Million
Q3 2022 Nov 14, 2022	SELL	$11.19 - $15.85 $85,625 - $121,284	-7,652 Reduced 6.03%	119,321 $1.43 Million
Q2 2022 Aug 15, 2022	SELL	$10.61 - $16.66 $1.41 Million - $2.21 Million	-132,585 Reduced 51.08%	126,973 $1.79 Million
Q1 2022 May 16, 2022	BUY	$8.97 - $14.03 $48,626 - $76,056	5,421 Added 2.13%	259,558 $3.21 Million
Q4 2021 Feb 14, 2022	SELL	$9.52 - $13.81 $259,677 - $376,695	-27,277 Reduced 9.69%	254,137 $2.86 Million
Q3 2021 Nov 12, 2021	BUY	$11.85 - $17.32 $3.33 Million - $4.87 Million	281,414 New	281,414 $3.57 Million

224

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $930M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.